Related Experiment Videos
Platelet serotonin kinetics in acute myocardial infarction before and after thrombolysis
Insights
Platelet activation, indicated by lower platelet counts and altered serotonin levels, is present in acute myocardial infarction (AMI). Thrombolytic treatment, not reperfusion, inhibits this platelet activation.
Area of Science:
- Cardiology
- Hematology
- Biochemistry
Background:
- Platelet activation plays a crucial role in the pathophysiology of acute myocardial infarction (AMI).
- Serotonin kinetics in platelets may serve as a marker for platelet activation in cardiovascular events.
Purpose of the Study:
- To investigate platelet count, serotonin uptake, and serotonin content in patients with evolving AMI.
- To evaluate the effect of thrombolytic therapy (streptokinase) on these platelet parameters.
Main Methods:
- Analysis of platelet count, serotonin uptake, and serotonin content in 11 AMI patients and 10 healthy controls.
- Measurements were taken before and after streptokinase administration.
Main Results:
- AMI patients exhibited significantly reduced platelet counts and increased platelet serotonin uptake and content compared to controls.
- Following thrombolysis, platelet counts increased, and serotonin uptake showed a trend towards normalization.
- Platelet serotonin content did not significantly change after thrombolysis.
Conclusions:
- Platelet activation is evident in evolving AMI, characterized by altered platelet serotonin kinetics.
- Thrombolytic therapy, specifically the agent streptokinase, inhibits platelet activation in AMI patients.
- The observed inhibition of platelet activation is attributed to the thrombolytic agent itself, rather than reperfusion.
Abstract:
Platelet count, platelet serotonin uptake and platelet serotonin content were analysed in 21 subjects consisting of 11 patients of evolving acute myocardial infarction (AMI) and 10 matched healthy controls before and after administration of streptokinase. Platelet counts were significantly reduced in AMI with a subsequent rise following thrombolysis. Platelet 5-HT uptake was also significantly increased in AMI and following thrombolysis, it showed a trend towards normalization. Platelet 5-HT content was significantly increased in AMI with no further significant change following thrombolysis. The results suggest that platelet activation as revealed by reduced platelet count and altered platelet serotonin kinetics, occurs in AMI and this activation is inhibited following thrombolysis. Further, it is also apparent that it is not the reperfusion but the thrombolytic agent that is responsible for inhibition of platelet activation.